
    
      This study consisted of 4 visits conducted during 3 sequential phases: the Run-in Phase
      (which included a screening visit and run-in period), Treatment Phase I and Treatment Phase
      II. In Phase I, subjects were randomized to either SystaneÂ® Balance or Saline and dosed 4
      times a day for 35 days. In Phase II (Day 35-90) subjects continued to dose with their
      assigned product on an as-needed basis.
    
  